Evommune, Inc.
EVMN
$20.49
$0.301.49%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.34% | -126.64% | 8.04% | 6.81% | 29.76% |
| Total Depreciation and Amortization | 7.06% | 4.82% | -17.07% | -0.53% | 4.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.28% | 7,269.39% | 100.56% | -3,684.02% | 408.33% |
| Change in Net Operating Assets | -215.75% | 207.94% | 158.04% | 57.11% | -651.66% |
| Cash from Operations | -64.70% | -73.32% | 63.24% | -9.66% | -29.10% |
| Capital Expenditure | 20.19% | 20.61% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.56% | -416.50% | -232.08% | 33.33% | 140.81% |
| Cash from Investing | 30.55% | -414.10% | -232.81% | 33.33% | 140.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.16% | 36.76% | 12.26% | -0.65% | -10.79% |
| Issuance of Common Stock | -25.49% | -- | -100.00% | 100.00% | -81.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 733.33% | 81.25% | -- | -- |
| Cash from Financing | -25.33% | 57,343.80% | -100.43% | 42,429.61% | -100.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -75.37% | 151.01% | -160.24% | 632.02% | -457.96% |